Tomer Kariv's most recent trade in Keros Therapeutics Inc was a trade of 10,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,250 | 5,250 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 2,859 | 2,859 | - | - | Stock Options (Right to Buy) | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 3,539 | 2,284,612 | - | 0 | Common Stock | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 3,539 | 0 | - | - | Call Options (obligation to sell) | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 1,914 | 0 | - | - | Call Options (obligation to sell) | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 1,914 | 1,226,412 | - | 0 | Common Stock | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 1,723 | 0 | - | - | Call Options (obligation to sell) | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 1,723 | 1,121,045 | - | 0 | Common Stock | ||
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 20,000 | 20,000 | - | - | Stock Options (Right to Buy) | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 01 Jun 2022 | 8,293 | 8,293 | - | - | Stock Options (right to buy) | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 01 Jun 2021 | 8,293 | 8,293 | - | - | Stock Option (right to buy) | ||
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 13 May 2021 | 2,630,487 | 3,679,797 (9%) | 6% | 1.3 | 3,551,157 | Common Stock |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 13 May 2021 | 1,422,222 | 1,989,551 (4%) | 3% | 1.4 | 1,920,000 | Common Stock |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 13 May 2021 | 1,280,624 | 1,791,470 (4%) | 3% | 1.3 | 1,728,842 | Common Stock |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 13 May 2021 | 592,592 | 616,592 (1%) | 1% | 1.3 | 799,999 | Common Stock |